GO:0015171 amino acid transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015171 amino acid transmembrane transporter activity is a molecular function that enables the transfer of amino acids from one side of a membrane to the other.
• Amino acid transporters are integral membrane proteins that mediate the uptake of essential amino acids, regulate cell volume, and supply substrates for protein synthesis.
• Key genes include SLC7A5 (LAT1), SLC1A5, SLC38A2 (SNAT2), SLC7A7 (y+LAT1), and SLC6A1 (GAT-1), each with distinct substrate specificities and coupling mechanisms.
• Mutations in amino acid transporters can alter substrate selectivity and transport activity, as shown for KAAT1 Y147F and GAT-1 transmembrane domain 10.
• Dysregulation of amino acid transport is implicated in cancer, lysinuric protein intolerance, and neurological disorders.
• CRISPR knockout, point mutation, and knock-in models are essential to dissect the causal roles of amino acid transporters in physiology and disease.
Description
Amino acid transmembrane transporter activity (GO:0015171) is a molecular function that enables the transfer of amino acids from one side of a membrane to the other. Amino acids are organic molecules containing an amino group and a carboxyl group, and their movement across cellular membranes is fundamental to metabolism, protein synthesis, and cell signaling. This activity is carried out by a diverse superfamily of integral membrane proteins that couple amino acid transport to ion gradients or exchange with other solutes. Researchers study these transporters to understand nutrient sensing, cell volume regulation, and the molecular basis of inherited and acquired diseases. The functional diversity of amino acid transporters arises from variations in substrate specificity, ion coupling, and tissue distribution. For example, the L-type amino acid transporter 1 (LAT1, SLC7A5) selectively transports large neutral amino acids and is overexpressed in many cancers. The neutral amino acid transporter SNAT2 (SLC38A2) plays a critical role in cell volume regulation and is regulated by osmotic stress. The y+L amino acid transporter-1 (y+LAT1, SLC7A7) associates with 4F2hc to mediate cationic and neutral amino acid transport, and mutations in SLC7A7 cause lysinuric protein intolerance. These examples illustrate how precise molecular mechanisms underlie physiological functions and disease states. Understanding GO:0015171 is essential for researchers in cell biology, neuroscience, and oncology because amino acid transporters are gatekeepers of cellular metabolism and potential therapeutic targets. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of the mechanisms, key genes, disease links, and experimental methods for studying amino acid transmembrane transporter activity.
amino acid transmembrane transporter activity At A Glance
| GO ID | GO:0015171 |
|---|---|
| GO term | amino acid transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | amino acid/choline transmembrane transporter activity; amino acid permease activity; amino acid transporter activity; general amino acid permease activity; hydroxy/aromatic amino acid permease activity |
| Major function | Enables the transfer of amino acids from one side of a membrane to the other |
| Substrates | Amino acids (organic molecules containing an amino group and a carboxyl group) |
| Cellular location | Integral component of membranes (plasma membrane, organelle membranes) |
| Representative genes | SLC7A5, SLC1A5, SLC38A2, SLC7A7, SLC6A1, SLC7A1, SLC3A2, SLC43A1, SLC16A10, SLC36A1 |
| Related diseases | Cancer, lysinuric protein intolerance, neurological disorders, metabolic disorders |
What Is GO:0015171?
GO:0015171 amino acid transmembrane transporter activity is defined as the molecular function that enables the transfer of amino acids from one side of a membrane to the other. Amino acids are organic molecules that contain an amino group and a carboxyl group. This activity is typically mediated by integral membrane proteins that facilitate the movement of amino acids across biological membranes, often coupled to ion gradients or other transport processes. Synonyms include amino acid/choline transmembrane transporter activity, amino acid permease activity, amino acid transporter activity, general amino acid permease activity, and hydroxy/aromatic amino acid permease activity.
Why Is amino acid transmembrane transporter activity Important in Cell Biology?
Amino acid transmembrane transporter activity is fundamental to cellular physiology because it controls the availability of amino acids for protein synthesis, energy metabolism, and signaling. Dysregulation of these transporters is linked to a wide range of human diseases, including cancer, where transporters such as LAT1 are overexpressed to support rapid growth, and inherited disorders such as lysinuric protein intolerance caused by mutations in SLC7A7. Moreover, amino acid transporters are critical for cell volume regulation, as demonstrated for SNAT2, and for neurotransmitter homeostasis in the nervous system, as shown for GAT-1. Understanding the molecular mechanisms of these transporters provides opportunities for therapeutic intervention and biomarker development.
• Amino acid transporters supply essential amino acids for protein synthesis and cell growth.
• They regulate cell volume and osmotic balance, as shown for SNAT2.
• Mutations in amino acid transporters cause inherited diseases such as lysinuric protein intolerance.
• Overexpression of LAT1 is associated with cancer progression and poor prognosis.
• GAT-1 is essential for GABA reuptake and neuronal inhibition.
• Amino acid transporters are targets for drug delivery and cancer therapy.
• They contribute to nutrient sensing and mTOR signaling.
• Transporters can be engineered for altered substrate specificity, as shown for KAAT1.
• They are involved in neurotransmitter recycling and neurological disorders.
• Amino acid transport activity is critical for immune cell function and metabolism.
Molecular Mechanism of amino acid transmembrane transporter activity
Substrate recognition and binding
In simple terms: The transporter first grabs the amino acid it will carry across the membrane.
Amino acid transporters recognize their substrates through specific binding pockets formed by transmembrane helices. For example, the L-type amino acid transporter 1 (LAT1) selectively binds large neutral amino acids such as phenylalanine and leucine, and structure-activity studies have shown that specific analogs are selectively transported. The polar amino acid residue in the TatA transmembrane helix is not strictly necessary for protein function, indicating that substrate recognition can tolerate some sequence variation. In the K+ amino acid transporter KAAT1, the Y147F mutation increases transport activity and alters substrate selectivity, demonstrating that a single residue can reshape the substrate binding pocket.
Conformational changes and translocation
In simple terms: After binding, the transporter changes shape to move the amino acid across the membrane.
Transporters undergo conformational changes to translocate substrates across the lipid bilayer. In the γ-aminobutyric acid (GABA) transporter GAT-1, an extra amino acid residue in transmembrane domain 10 is required for efficient ion-coupled transport, highlighting the importance of helical packing for conformational transitions. Similarly, interactions between charged amino acid residues within transmembrane helices in the sulfate transporter SHST1 are critical for function, suggesting that electrostatic interactions stabilize transport intermediates. These studies illustrate that precise structural features govern the translocation step.
Ion coupling and exchange mechanisms
In simple terms: Many transporters use ions like sodium or potassium to power amino acid movement.
Amino acid transport is often coupled to ion gradients. The y+L amino acid transporter-1 (y+LAT1) associates with 4F2hc to encode the amino acid transport activity y+L, which mediates cationic and neutral amino acid transport in a sodium-independent manner. In contrast, GAT-1 is a sodium- and chloride-dependent transporter, and its ion-coupled transport requires specific residues in transmembrane domain 10. The K+ amino acid transporter KAAT1 uses potassium ions to drive amino acid uptake, and the Y147F mutation alters its transport activity. These examples demonstrate the diversity of ion coupling mechanisms.
Regulation by cellular signals
In simple terms: Cells can adjust how many transporters are active or where they are located.
Amino acid transporter activity is regulated at multiple levels, including transcription, trafficking, and post-translational modifications. The neutral amino acid transporter SNAT2 is regulated by cell volume changes and osmotic stress, and it plays a key role in cell volume regulation. Monocarboxylate transporter 10 (MCT10) can be engineered to expand its substrate spectrum through few amino acid exchanges, indicating that substrate specificity is tunable. These regulatory mechanisms allow cells to adapt to changing nutrient availability and metabolic demands.
Key Genes Involved in GO:0015171 amino acid transmembrane transporter activity
The following genes encode proteins that mediate amino acid transmembrane transporter activity, each with distinct substrate specificities, tissue distributions, and physiological roles.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC7A5 | L-type amino acid transporter 1 (LAT1); transports large neutral amino acids | Overexpressed in cancer; target for drug delivery |
| SLC1A5 | Neutral amino acid transporter; glutamine uptake | Cancer metabolism; mTOR activation |
| SLC38A2 | SNAT2; neutral amino acid transporter; cell volume regulation | Osmotic stress response; mTOR signaling |
| SLC7A7 | y+LAT1; cationic and neutral amino acid transport; associates with 4F2hc | Lysinuric protein intolerance |
| SLC6A1 | GAT-1; GABA transporter; ion-coupled transport | Neurological disorders; epilepsy |
| SLC7A1 | CAT-1; cationic amino acid transporter | Arginine transport; nitric oxide synthesis |
| SLC3A2 | 4F2hc; chaperone for LAT1 and y+LAT1 | Cell surface expression of transporters |
| SLC43A1 | LAT3; large neutral amino acid transporter | Cancer and metabolic studies |
| SLC16A10 | MCT10; aromatic amino acid transporter | Thyroid hormone transport; substrate specificity |
| SLC36A1 | PAT1; proton-coupled amino acid transporter | Intestinal absorption; drug transport |
| SLC1A1 | EAAT3; glutamate transporter | Neurotransmission; excitotoxicity |
| SLC1A2 | EAAT2; glutamate transporter | Neurodegeneration; stroke |
| SLC6A4 | SERT; serotonin transporter | Depression; psychostimulant action |
| SLC6A2 | NET; norepinephrine transporter | Attention deficit hyperactivity disorder |
| SLC6A3 | DAT; dopamine transporter | Parkinson's disease; addiction |
| SLC7A11 | xCT; cystine/glutamate antiporter | Ferroptosis; cancer therapy |
| SLC38A1 | SNAT1; glutamine transporter | Cancer metabolism; neuronal function |
| SLC38A9 | Lysosomal amino acid transporter | mTORC1 signaling |
How Is amino acid transmembrane transporter activity Regulated?
Amino acid transmembrane transporter activity is regulated at multiple levels. Transcriptional regulation controls the abundance of transporter mRNAs in response to nutrient availability and stress. For example, SNAT2 expression is regulated by osmotic stress and cell volume changes. Post-translational modifications, such as phosphorylation and ubiquitination, modulate transporter trafficking and stability. The association of y+LAT1 with 4F2hc is required for its cell surface expression and function. Additionally, ion gradients and membrane potential influence transport rates, as seen for GAT-1 and KAAT1. Signaling pathways such as mTORC1 sense amino acid levels and feedback to regulate transporter expression and activity.
amino acid transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC7A5 | Cancer; tumor growth and proliferation | Knockout and overexpression in cancer cell lines |
| SLC7A7 | Lysinuric protein intolerance | Patient-derived fibroblasts; knock-in mouse models |
| SLC6A1 | Epilepsy; neurological disorders | Knockout mice; point mutations in GAT-1 |
| SLC38A2 | Cell volume regulation; metabolic stress | Knockout cells; osmotic stress assays |
| SLC16A10 | Thyroid hormone transport; substrate specificity | Point mutation and overexpression studies |
Amino acid transporters in cancer
Many amino acid transporters are overexpressed in cancer to support increased nutrient demands. LAT1 (SLC7A5) is highly expressed in various tumors and correlates with poor prognosis, making it a target for cancer therapy and imaging. SLC1A5 and SLC7A11 are also implicated in cancer metabolism and ferroptosis. Targeting these transporters can inhibit tumor growth and sensitize cancer cells to chemotherapy.
Lysinuric protein intolerance
Mutations in SLC7A7, which encodes y+LAT1, cause lysinuric protein intolerance, a rare inherited disorder characterized by defective cationic amino acid transport in the kidney and intestine. This leads to hyperammonemia, protein intolerance, and growth retardation. The identification of SLC7A7 as the causative gene has provided insights into the molecular basis of the disease and potential therapeutic approaches.
Neurological disorders and GABA transport
GAT-1 (SLC6A1) is responsible for reuptake of GABA, the major inhibitory neurotransmitter. Dysfunction of GAT-1 is associated with epilepsy and other neurological disorders. Studies on GAT-1 transmembrane domain 10 have revealed critical residues for ion-coupled transport, offering potential targets for antiepileptic drugs.
Metabolic and osmotic disorders
SNAT2 (SLC38A2) plays a key role in cell volume regulation and is activated by hypertonic stress. Dysregulation of SNAT2 has been linked to metabolic disorders and cancer. Understanding its regulation may provide therapeutic strategies for conditions involving osmotic imbalance.
From amino acid transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC7A5 affect cancer cell proliferation? | CRISPR knockout in cancer cell lines |
| Does the Y147F mutation in KAAT1 alter substrate selectivity? | Point mutation knock-in in Xenopus oocytes |
| Can GAT-1 transmembrane domain 10 mutations impair ion coupling? | Site-directed mutagenesis and electrophysiology |
| Does SLC7A7 knock-in rescue lysinuric protein intolerance phenotypes? | Knock-in mouse models |
| Does overexpression of SNAT2 protect against osmotic stress? | Overexpression in mammalian cells |
| Can MCT10 substrate spectrum be expanded by amino acid exchanges? | Overexpression and transport assays |
How to Study the amino acid transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled uptake assay | Transport rate and substrate specificity | Characterization of LAT1, SNAT2, y+LAT1 |
| Two-electrode voltage clamp | Transport currents and ion coupling | Electrogenic transporters like GAT-1, KAAT1 |
| Fluorescence-based transport assay | Real-time transport activity | High-throughput screening |
| Site-directed mutagenesis | Functional role of specific residues | GAT-1, KAAT1, MCT10 |
| Cryo-EM | Three-dimensional structure | Substrate binding and conformational states |
| RNA-seq | Transporter gene expression | Tissue-specific expression profiling |
| Proteomics | Protein abundance and interactions | Transporter complexes like y+LAT1/4F2hc |
| CRISPR knockout | Loss-of-function phenotypes | Causal role in disease models |
Transport assays
Radiolabeled amino acid uptake assays are the gold standard for measuring amino acid transmembrane transporter activity. Cells expressing the transporter of interest are incubated with radiolabeled substrates, and uptake is quantified by scintillation counting. This method has been used to characterize LAT1, SNAT2, and y+LAT1.
Electrophysiology
For electrogenic transporters such as GAT-1 and KAAT1, two-electrode voltage clamp or patch clamp can measure transport currents in real time. This approach provides kinetic parameters and reveals ion coupling stoichiometry.
Fluorescence-based assays
Fluorescent amino acid analogs or pH-sensitive dyes can be used to monitor transport activity in live cells. These assays are amenable to high-throughput screening for transporter inhibitors or activators.
Structural biology and mutagenesis
Cryo-EM and X-ray crystallography provide structural insights into substrate binding and conformational changes. Site-directed mutagenesis, as performed for GAT-1 and KAAT1, validates the functional importance of specific residues.
How CRISPR Can Be Used to Study GO:0015171 amino acid transmembrane transporter activity
Knockout
CRISPR knockout of amino acid transporter genes is used to determine their contribution to cellular uptake, growth, and disease phenotypes. For example, knockout of SLC7A5 in cancer cells reduces proliferation and mTOR signaling. Knockout of SLC7A7 in cell models can mimic lysinuric protein intolerance.
Point Mutation
Point mutations can be introduced to study structure-function relationships. The Y147F mutation in KAAT1 was generated to show increased transport activity and altered substrate selectivity. Similarly, mutations in GAT-1 transmembrane domain 10 impair ion-coupled transport.
Knock-in
Knock-in models allow expression of mutant transporters under endogenous regulatory elements. For example, knock-in of disease-associated SLC7A7 mutations can recapitulate lysinuric protein intolerance in mice. Knock-in of tagged transporters enables localization and interaction studies.
Overexpression
Overexpression of amino acid transporters in cell lines is used to study transport kinetics and substrate specificity. Overexpression of SNAT2 protects cells from osmotic stress, and overexpression of MCT10 variants reveals expanded substrate spectra.
How EDITGENE Supports amino acid transmembrane transporter activity Research
Researchers studying amino acid transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as cancer cell growth, neuronal function, or metabolic regulation. CRISPR-based models provide the precision required to dissect these causal relationships.
Contact EDITGENE today to design your custom CRISPR model for amino acid transmembrane transporter activity research.
Frequently Asked Questions About amino acid transmembrane transporter activity
What is amino acid transmembrane transporter activity?
It is a molecular function (GO:0015171) that enables the transfer of amino acids from one side of a membrane to the other, typically mediated by integral membrane proteins.
What genes are involved in amino acid transmembrane transporter activity?
Key genes include SLC7A5 (LAT1), SLC1A5, SLC38A2 (SNAT2), SLC7A7 (y+LAT1), SLC6A1 (GAT-1), and many others.
How is amino acid transport measured?
Common methods include radiolabeled uptake assays, electrophysiology, and fluorescence-based assays.
What diseases are linked to amino acid transporters?
Diseases include cancer, lysinuric protein intolerance, epilepsy, and metabolic disorders.
What is the role of LAT1 in cancer?
LAT1 (SLC7A5) is overexpressed in many cancers and supports tumor growth by supplying large neutral amino acids.
How does SNAT2 regulate cell volume?
SNAT2 (SLC38A2) is activated by hypertonic stress and mediates amino acid uptake to restore cell volume.
What is lysinuric protein intolerance?
It is a rare inherited disorder caused by mutations in SLC7A7, leading to defective cationic amino acid transport.
Can CRISPR be used to study amino acid transporters?
Yes, CRISPR knockout, point mutation, and knock-in models are widely used to dissect transporter function and disease mechanisms.
What is the substrate specificity of GAT-1?
GAT-1 (SLC6A1) transports GABA and is dependent on sodium and chloride ions.
How can I create a knockout of SLC7A5?
EDITGENE provides custom CRISPR knockout cell lines and can design validated guides for SLC7A5 and other transporters.
Conclusion
Amino acid transmembrane transporter activity (GO:0015171) is a fundamental molecular function that governs nutrient uptake, cell volume, and neurotransmission. The diversity of transporters and their roles in cancer, inherited diseases, and neurological disorders make them important research targets. CRISPR-based models, combined with transport assays and structural studies, provide powerful tools to dissect their mechanisms and develop therapeutic strategies. EDITGENE offers comprehensive services to support these investigations.
References
- 1. Chen S et al.. 2024. Structure-activity characteristics of phenylalanine analogs selectively transported by L-type amino acid transporter 1 (LAT1).. Sci Rep 14(1):4651 PMID: 38409393
- 2. Hao B et al.. 2023. The polar amino acid in the TatA transmembrane helix is not strictly necessary for protein function.. J Biol Chem 299(4):102998 PMID: 36764519
- 3. Liu Z et al.. 2003. K+ amino acid transporter KAAT1 mutant Y147F has increased transport activity and altered substrate selectivity.. J Exp Biol 206(Pt 2):245-54 PMID: 12477895
- 4. Johannes J et al.. 2016. Few Amino Acid Exchanges Expand the Substrate Spectrum of Monocarboxylate Transporter 10.. Mol Endocrinol 30(7):796-808 PMID: 27244477
- 5. Franchi-Gazzola R et al.. 2006. The role of the neutral amino acid transporter SNAT2 in cell volume regulation.. Acta Physiol (Oxf) 187(1-2):273-83 PMID: 16734764
- 6. Shelden MC et al.. 2003. Interactions between charged amino acid residues within transmembrane helices in the sulfate transporter SHST1.. Biochemistry 42(44):12941-9 PMID: 14596609
- 7. Dayan O et al.. 2017. An Extra Amino Acid Residue in Transmembrane Domain 10 of the γ-Aminobutyric Acid (GABA) Transporter GAT-1 Is Required for Efficient Ion-coupled Transport.. J Biol Chem 292(13):5418-5428 PMID: 28213519
- 8. Torrents D et al.. 1998. Identification and characterization of a membrane protein (y+L amino acid transporter-1) that associates with 4F2hc to encode the amino acid transport activity y+L. A candidate gene for lysinuric protein intolerance.. J Biol Chem 273(49):32437-45 PMID: 9829974
